目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global cancer biologics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global cancer biologics market 2018 - 2022 ($ billion)
4.2 Product Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.3 Route of administration Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Route of administration Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2023-2028 (%)
Exhibit 31: Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Monoclonal antibodies - Market size and forecast 2023-2028
Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2023-2028 (%)
6.4 Cell and gene therapy - Market size and forecast 2023-2028
Exhibit 38: Chart on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Cell and gene therapy - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Cell and gene therapy - Year-over-year growth 2023-2028 (%)
6.5 Vaccines - Market size and forecast 2023-2028
Exhibit 42: Chart on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Vaccines - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Vaccines - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Vaccines - Year-over-year growth 2023-2028 (%)
6.6 Others - Market size and forecast 2023-2028
Exhibit 46: Chart on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 47: Data Table on Others - Market size and forecast 2023-2028 ($ billion)
Exhibit 48: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibit 49: Data Table on Others - Year-over-year growth 2023-2028 (%)
6.7 Market opportunity by Product
Exhibit 50: Market opportunity by Product ($ billion)
Exhibit 51: Data Table on Market opportunity by Product ($ billion)

7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 52: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 53: Data Table on Route of Administration - Market share 2023-2028 (%)
7.2 Comparison by Route of Administration
Exhibit 54: Chart on Comparison by Route of Administration
Exhibit 55: Data Table on Comparison by Route of Administration
7.3 Injectable - Market size and forecast 2023-2028
Exhibit 56: Chart on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Injectable - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
7.4 Oral - Market size and forecast 2023-2028
Exhibit 60: Chart on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 61: Data Table on Oral - Market size and forecast 2023-2028 ($ billion)
Exhibit 62: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 63: Data Table on Oral - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Route of Administration
Exhibit 64: Market opportunity by Route of Administration ($ billion)
Exhibit 65: Data Table on Market opportunity by Route of Administration ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 71: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 75: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 79: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 87: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 103: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 104: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 105: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 106: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Amgen Inc.
Exhibit 115: Amgen Inc. - Overview
Exhibit 116: Amgen Inc. - Product / Service
Exhibit 117: Amgen Inc. - Key offerings
12.4 AstraZeneca Plc
Exhibit 118: AstraZeneca Plc - Overview
Exhibit 119: AstraZeneca Plc - Product / Service
Exhibit 120: AstraZeneca Plc - Key news
Exhibit 121: AstraZeneca Plc - Key offerings
12.5 Bayer AG
Exhibit 122: Bayer AG - Overview
Exhibit 123: Bayer AG - Business segments
Exhibit 124: Bayer AG - Key news
Exhibit 125: Bayer AG - Key offerings
Exhibit 126: Bayer AG - Segment focus
12.6 Biocon Ltd.
Exhibit 127: Biocon Ltd. - Overview
Exhibit 128: Biocon Ltd. - Business segments
Exhibit 129: Biocon Ltd. - Key offerings
Exhibit 130: Biocon Ltd. - Segment focus
12.7 Biogen Inc.
Exhibit 131: Biogen Inc. - Overview
Exhibit 132: Biogen Inc. - Product / Service
Exhibit 133: Biogen Inc. - Key offerings
12.8 Bristol Myers Squibb Co.
Exhibit 134: Bristol Myers Squibb Co. - Overview
Exhibit 135: Bristol Myers Squibb Co. - Product / Service
Exhibit 136: Bristol Myers Squibb Co. - Key news
Exhibit 137: Bristol Myers Squibb Co. - Key offerings
12.9 Celltrion Co. Ltd.
Exhibit 138: Celltrion Co. Ltd. - Overview
Exhibit 139: Celltrion Co. Ltd. - Product / Service
Exhibit 140: Celltrion Co. Ltd. - Key offerings
12.10 Cipla Ltd.
Exhibit 141: Cipla Ltd. - Overview
Exhibit 142: Cipla Ltd. - Business segments
Exhibit 143: Cipla Ltd. - Key news
Exhibit 144: Cipla Ltd. - Key offerings
Exhibit 145: Cipla Ltd. - Segment focus
12.11 Dr Reddys Laboratories Ltd.
Exhibit 146: Dr Reddys Laboratories Ltd. - Overview
Exhibit 147: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 148: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 149: Dr Reddys Laboratories Ltd. - Segment focus
12.12 Eli Lilly and Co.
Exhibit 150: Eli Lilly and Co. - Overview
Exhibit 151: Eli Lilly and Co. - Product / Service
Exhibit 152: Eli Lilly and Co. - Key news
Exhibit 153: Eli Lilly and Co. - Key offerings
12.13 F. Hoffmann La Roche Ltd.
Exhibit 154: F. Hoffmann La Roche Ltd. - Overview
Exhibit 155: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 156: F. Hoffmann La Roche Ltd. - Key news
Exhibit 157: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 158: F. Hoffmann La Roche Ltd. - Segment focus
12.14 Gilead Sciences Inc.
Exhibit 159: Gilead Sciences Inc. - Overview
Exhibit 160: Gilead Sciences Inc. - Product / Service
Exhibit 161: Gilead Sciences Inc. - Key news
Exhibit 162: Gilead Sciences Inc. - Key offerings
12.15 GlaxoSmithKline Plc
Exhibit 163: GlaxoSmithKline Plc - Overview
Exhibit 164: GlaxoSmithKline Plc - Business segments
Exhibit 165: GlaxoSmithKline Plc - Key news
Exhibit 166: GlaxoSmithKline Plc - Key offerings
Exhibit 167: GlaxoSmithKline Plc - Segment focus
12.16 Jazz Pharmaceuticals Plc
Exhibit 168: Jazz Pharmaceuticals Plc - Overview
Exhibit 169: Jazz Pharmaceuticals Plc - Product / Service
Exhibit 170: Jazz Pharmaceuticals Plc - Key news
Exhibit 171: Jazz Pharmaceuticals Plc - Key offerings
12.17 Merck KGaA
Exhibit 172: Merck KGaA - Overview
Exhibit 173: Merck KGaA - Business segments
Exhibit 174: Merck KGaA - Key news
Exhibit 175: Merck KGaA - Key offerings
Exhibit 176: Merck KGaA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 177: Inclusions checklist
Exhibit 178: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 179: Currency conversion rates for US$
13.4 Research methodology
Exhibit 180: Research methodology
Exhibit 181: Validation techniques employed for market sizing
Exhibit 182: Information sources
13.5 List of abbreviations
Exhibit 183: List of abbreviations